These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32595524)

  • 21. Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channels.
    Haick JM; Byron KL
    Pharmacol Ther; 2016 Sep; 165():14-25. PubMed ID: 27179745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kv7 channels as targets for the treatment of pain.
    Wickenden AD; McNaughton-Smith G
    Curr Pharm Des; 2009; 15(15):1773-98. PubMed ID: 19442190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
    Bentzen BH; Schmitt N; Calloe K; Dalby Brown W; Grunnet M; Olesen SP
    Neuropharmacology; 2006 Nov; 51(6):1068-77. PubMed ID: 16904708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of Kv7 Channel Currents by Echinocystic Acid.
    Geng D; Li Y; Zheng R; Wang R; Yang B; Zhang H; Zhang Y; Zhang F
    Mol Pharmacol; 2023 Aug; 104(2):42-50. PubMed ID: 37280100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Determinants of Kv7.5 Potassium Channels That Confer Changes in Phosphatidylinositol 4,5-Bisphosphate (PIP
    Brueggemann LI; Cribbs LL; Byron KL
    Mol Pharmacol; 2020 Mar; 97(3):145-158. PubMed ID: 31871302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of potassium channels in Kv7.2 G271V mutant causing early onset familial epilepsy.
    Wang J; Li Y; Hui Z; Cao M; Shi R; Zhang W; Geng L; Zhou X
    Brain Res; 2015 Aug; 1616():112-22. PubMed ID: 25960349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites.
    Miceli F; Soldovieri MV; Ambrosino P; Manocchio L; Mosca I; Taglialatela M
    Curr Med Chem; 2018; 25(23):2637-2660. PubMed ID: 29022505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
    Leaf A; Xiao YF; Kang JX; Billman GE
    Pharmacol Ther; 2003 Jun; 98(3):355-77. PubMed ID: 12782244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G protein βγ regulation of KCNQ-encoded voltage-dependent K channels.
    Stott JB; Greenwood IA
    Front Physiol; 2024; 15():1382904. PubMed ID: 38655029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate.
    Li Y; Gamper N; Hilgemann DW; Shapiro MS
    J Neurosci; 2005 Oct; 25(43):9825-35. PubMed ID: 16251430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention.
    Mackie AR; Byron KL
    Mol Pharmacol; 2008 Nov; 74(5):1171-9. PubMed ID: 18684841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of K
    Baculis BC; Zhang J; Chung HJ
    Front Physiol; 2020; 11():568667. PubMed ID: 33071824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tannic acid modulates excitability of sensory neurons and nociceptive behavior and the Ionic mechanism.
    Zhang X; Zhang H; Zhou N; Xu J; Si M; Jia Z; Du X; Zhang H
    Eur J Pharmacol; 2015 Oct; 764():633-642. PubMed ID: 26134502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic AMP-Dependent Regulation of Kv7 Voltage-Gated Potassium Channels.
    van der Horst J; Greenwood IA; Jepps TA
    Front Physiol; 2020; 11():727. PubMed ID: 32695022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
    Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR
    J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K
    Bientinesi R; Mancuso C; Martire M; Bassi PF; Sacco E; Currò D
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):127-137. PubMed ID: 27761601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insight into KCNQ (Kv7) channel assembly and channelopathy.
    Howard RJ; Clark KA; Holton JM; Minor DL
    Neuron; 2007 Mar; 53(5):663-75. PubMed ID: 17329207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A possible link between KCNQ2- and STXBP1-related encephalopathies: STXBP1 reduces the inhibitory impact of syntaxin-1A on M current.
    Devaux J; Dhifallah S; De Maria M; Stuart-Lopez G; Becq H; Milh M; Molinari F; Aniksztejn L
    Epilepsia; 2017 Dec; 58(12):2073-2084. PubMed ID: 29067685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of KCNE subunits on KCNQ1 (Kv7.1) channel membrane surface targeting.
    Roura-Ferrer M; Solé L; Oliveras A; Dahan R; Bielanska J; Villarroel A; Comes N; Felipe A
    J Cell Physiol; 2010 Nov; 225(3):692-700. PubMed ID: 20533308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.
    Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF
    J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.